Copper Intrauterine Devices Tied to Lower Risk for Cervical Cancer
Findings based on comparison to hormonal intrauterine devices.
Contraception
FDA Approves New Contraceptive Patch
The FDA has approved Twirla (levonorgestrel and ethinyl estradiol) transdermal system (Agile Therapeutics) as a method of contraception for use in women of reproductive potential with a body mass index (BMI) <30kg/m2 for whom a combined hormonal contraceptive is appropriate.
Hormonal vs Nonhormonal Contraception and the Impact on Seizure Frequency
Compared to nonhormonal contraception, hormonal contraception appears to pose a greater risk for increased seizure frequency in women with epilepsy.
Adolescent Girls Using Oral Contraceptives Have Higher Self-Reported Depressive Symptoms
Symptoms of depression are associated with oral contraceptive use in 16-year-old girls compared with adolescents and young women up to 25 years of age.
Telecontraception Seems a Promising Option for Patients
Adherence to guidelines high for patients with medical contraindications to oral contraceptives.
ACOG Updates Guidance on OTC Contraception Access
Over-the-counter hormonal contraception access recommended with no age restrictions.
Adolescent Oral Contraceptive Use Tied to Later Depression Risk
Findings show long-term impact, regardless of current oral contraception use in adulthood.
Oral Contraceptive Recalled Due to Possibility of Reduced Efficacy
Jubilant Cadista Pharmaceuticals is recalling 1 lot of the combination oral contraceptive Drospirenone and Ethinyl Estradiol Tablets, USP, 3mg/0.02mg due to the possibility of decreased product efficacy.
HIV Risk Does Not Differ With 3 Contraceptive Methods
No significant difference seen with use of DMPA-IM, copper IUD device, levonorgestrel implant in African women.
Oral Contraceptive Pill May Protect Against ACL Tears
Risk for acute cruciate ligament reconstruction reduced while on OCP, especially for 15- to 19-year-olds.
-
Loading...
-
Loading...
Next post in Ob/Gyn Information Center
